Trial
NCT02975583
Vorapaxar and Lower Extremity Bypass Grafts
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Vanderbilt University
Collaborators
Merck Sharp & Dohme LLC
Condition
Peripheral Artery Disease
Intervention
Vorapaxar
Why stopped
We could not secure adequate medication
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-25